Showing results (1-10 of 416) with videos related to
Sort By:
Pageof 42
Cardiovascular Drug Reviews|October 25, 2002
The low molecular weight heparin, tinzaparin, in thrombosis and beyondShaker A MousaMedicinal Research Reviews|December 25, 2002
alphav Vitronectin receptors in vascular-mediated disordersShaker A MousaCurrent Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Heparin and low molecular weight heparin in thrombosis and beyondShaker A MousaJournal of Cellular Biochemistry|February 22, 2005
Effect of low molecular weight heparin and different heparin molecular weight fractions on the activity of the matrix-degrading enzyme aggrecanase: structure-function relationshipShaker A MousaDrugs of Today (Barcelona, Spain : 1998)|June 28, 2006
Role of current and emerging antithrombotics in thrombosis and cancerShaker A MousaMethods in Molecular Biology (Clifton, N.J.)|July 10, 2010
In vivo models for the evaluation of antithrombotics and thrombolyticsShaker A MousaTimely Topics in Medicine. Cardiovascular Diseases|October 27, 2006
Role of current and emerging antithrombotics in thrombosis and cancerShaker A MousaBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 21, 2006
In-vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists and thrombolytics on platelet/fibrin-mediated clot dynamics in human whole blood using thrombelastographyShaker A MousaSeminars in Thrombosis and Hemostasis|July 17, 2007
Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation: emerging linksShaker A MousaSeminars in Thrombosis and Hemostasis|April 16, 2004
Low-molecular-weight heparin in thrombosis and cancerShaker A MousaPageof 42